G. Niklas Norén

发表

Temporal pattern discovery in longitudinal electronic patient records

G. Niklas Norén, Johan Hopstadius, Andrew Bate, 2010, Data Mining and Knowledge Discovery.

Adjustment for potential confounders in adverse drug reaction surveillance

G. Niklas Norén, Johan Hopstadius, Andrew Bate, 2007 .

Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers

Yu-Chuan Li, George Hripcsak, Patrick B. Ryan, 2015, MedInfo.

Cheminformatics-aided pharmacovigilance: application to Stevens-Johnson Syndrome

Ivan Rusyn, G. Niklas Norén, I. Ralph Edwards, 2015, J. Am. Medical Informatics Assoc..

Temporal pattern discovery for trends and transient effects: its application to patient records

G. Niklas Norén, Johan Hopstadius, Andrew Bate, 2008, KDD.

Duplicate detection in adverse drug reaction surveillance

G. Niklas Norén, Andrew Bate, I. Ralph Edwards, 2007, Data Mining and Knowledge Discovery.

A hit-miss model for duplicate detection in the WHO drug safety database

G. Niklas Norén, Andrew Bate, Roland Orre, 2005, KDD '05.

Large-scale regression-based pattern discovery: The example of screening the WHO global drug safety database

David Madigan, G. Niklas Norén, Andrew Bate, 2010 .

Statistical methods for knowledge discovery in adverse drug reaction surveillance.

G. Niklas Norén, G. N. Norén, 2007 .

Large‐scale regression‐based pattern discovery: The example of screening the WHO global drug safety database

David Madigan, G. Niklas Norén, Andrew Bate, 2010, Stat. Anal. Data Min..

A bayesian recurrent neural network for unsupervised pattern recognition in large incomplete data sets

Stefan Arnborg, G. Niklas Norén, Andrew Bate, 2005, Int. J. Neural Syst..

Robust discovery of local patterns: subsets and stratification in adverse drug reaction surveillance

G. Niklas Norén, Johan Hopstadius, G. N. Norén, 2012, IHI '12.

Large-Scale Regression-Based Pattern Discovery in International Adverse Drug Reaction Surveillance

David Madigan, G. Niklas Norén, Andrew Bate, 2008 .

Data Mining in Pharmacovigilance: A View from the Uppsala Monitoring Centre

G. Niklas Norén, Andrew Bate, I. Ralph Edwards, 2007 .

Case Based Imprecision Estimates for Bayes Classifiers with the Bayesian Bootstrap

G. Niklas Norén, Roland Orre, 2005, Machine Learning.

Consensus clustering for case series identification and adverse event profiles in pharmacovigilance

G. Niklas Norén, Eva-Lisa Meldau, Rebecca E. Chandler, 2021, Artif. Intell. Medicine.

Opportunities and challenges of adverse drug reaction surveillance in electronic patient records

G. Niklas Norén, I. Ralph Edwards, 2010 .

Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest

Christophe G. Lambert, Patrick B. Ryan, J. Marc Overhage, 2014, Drug Safety.

Statistical methods for large scale exploratory analysis of postmarketing drug safety data

G. Niklas Norén, 2005 .

Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank

G. Niklas Norén, Ola Caster, Kristina Juhlin, 2014, Drug Safety.

vigiGrade: A Tool to Identify Well-Documented Individual Case Reports and Highlight Systematic Data Quality Issues

G. Niklas Norén, Tomas Bergvall, Marie Lindquist, 2013, Drug Safety.

Good Signal Detection Practices: Evidence from IMI PROTECT

G. Niklas Norén, Andrew Bate, Kristina Juhlin, 2016, Drug Safety.

A Decade of Data Mining and Still Counting

G. Niklas Norén, Manfred Haubenand, 2010, Drug safety.

Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project

G. Niklas Norén, Ola Caster, Marie-Laure Kürzinger, 2018, Drug Safety.